Thus, the transmission of mitochondrial damage to the nucleus, where it manifests as DNA double-strand breaks via the PINK1–Parkin–BRCA1 axis, may be relevant not only in the field of oncology, but also in the study of neurodegenerative diseases. This evidence concerns the gene PRKN and neurodegenerative disease.